According to the WHO, antibiotic resistance is increasing to dangerous levels worldwide. Novel resistance mechanisms are emerging and spreading globally. There are numerous mechanisms reported for antibiotic resistance. In some cases, as bacteria adapt to the continuous presence of antibiotics, it becomes increasingly more resistant. Resistant bacteria are much more challenging to get rid of and control infections that they cause. Today, the need for effective antibiotics is more critical than ever. However, few new antibiotics are in the development pipeline. Consequently, food pathogens should not be antibiotic-resistant. The European Center for Disease Prevention and Control (ECDC) and the European...
ruth
On February 17, 2022, the FDA announced that it is investigating four consumer complaints of infant illness- related to products from Abbott Nutrition’s Sturgis, MI facility. The FDA received consumer complaints about infants who had consumed powdered infant formula produced by Abbott Nutrition’s Sturgis, MI facility. These complaints include three reports of Cronobacter sakazakii infections and one of Salmonella Newport infection of infants. All four cases related to these complaints were hospitalized, and the Cronobacter may have contributed to a death in one case. On the same day of the FDA notice, the CFIA announced their recall of the Abbott...
ruth
WHO estimates that around the world, almost 1 in 10 people gets sick eating contaminated food each year. Food contamination results in 420,000 deaths and the loss of 33 million healthy life years. Food safety is a global issue, but each outbreak is local. All countries are not equal in their food safety achievements. To better understand food safety globally, we are looking for volunteers to help us cover the world in our group and on the adjacent website http://ask-bioexpert.com/. We are asking for help covering recalls, outbreaks, and new regulations worldwide. Also, it is essential to include new technologies...
ruth
It is crucial to have a technology that can rapidly and accurately distinguish between bacterial and viral infections. Such technology can reduce the overuse of antibiotics in viral infections. MeMed Diagnostics (developed in Israel) is a personalized diagnostics company founded in 2009. The company developed an immunoassay test to differentiate bacteria from viruses using chemiluminescence detection technology. The devices distinguish between bacterial and viral infections based on patients’ immune responses to different infection types, enabling physicians to get rapid (15 minutes) and actionable clinical information to make informed antibiotic treatment decisions. The MeMed Key cartridges allow simultaneous measurements of up...